Pharmaceutical Product Development LLC

Pharmaceutical Product Development LLC

Pharmaceutical Product Development LLC

Overview
Date Founded

2012

Headquarters

929 North Front Street,Wilmington, NC 28401-3331

Type of Company

Private

Employees (Worldwide)

10K - 1M

Industries

Other Business & Consulting Services
Commercial Scientific Research
Holding Companies
Medical Products & Equipment
Pharmaceuticals
Medical Support Services
Biotechnology

Company Description

Pharmaceutical Product Development LLC operates as a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC.

Contact Data
Trying to get in touch with decision makers at Pharmaceutical Product Development LLC? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman & Chief Executive Officer

Executive Director, Laboratory Operations

Executive Vice President & Chief Financial Officer

Chief Operating Officer

Executive Vice President, General Counsel & Chief Administrative Officer

Executive Vice President & Chief Human Resources Officer

Executive Vice President & Chief Human Resource Officer

Senior Vice President & Global Head of BioTech

Executive Vice President, Global Clinical Development

Executive Director

Board of Directors

Global Chair at GLG Institute

Former Senior Vice President, Finance & Treasurer at PepsiCo, Inc.

Managing Director & Head of Global Health Care at The Carlyle Group LP (Corporate Private Equity)

Partner at Hellman & Friedman LLC

Partner at Hellman & Friedman LLC

Chairman of the Board, Chief Executive Officer, Co-Founder at GNS Healthcare, Inc.

Director at Hellman & Friedman LLC

Principal at The Carlyle Group LP (Corporate Private Equity)

Chairman & Chief Executive Officer at PPD, Inc.

Paths to Pharmaceutical Product Development LLC
Potential Connections via
Relationship Science
You
Pharmaceutical Product Development LLC
Recent Transactions
Details Hidden

The Carlyle Group, Inc., Abu Dhabi Investment Authority (Private Equity), Pharmaceutical Product Development LLC /Private Group purchase Pharmaceutical Product Development LLC from The Carlyle Group LP (Corporate Private Equity), Hellman & Friedman LLC

Details Hidden

Pharmaceutical Product Development LLC, The Carlyle Group LP (Corporate Private Equity), Hellman & Friedman LLC purchase Evidera, Inc. from Symphony Technology Group LLC

Details Hidden

Pharmaceutical Product Development LLC, Hellman & Friedman LLC purchase Synexus Clinical Research Ltd. from Lloyds Development Capital (Holdings) Ltd.

Transaction Advisors
Accountant

Advised onPharmaceutical Product Development LLC purchases Applied Bioscience International, Inc.

Accountant

Advised onPharmaceutical Product Development LLC purchases Medical Research Laboratories International, Inc.

Legal Advisor

Advised onThe Carlyle Group, Inc., Abu Dhabi Investment Authority (Private Equity), Pharmaceutical Product Development LLC /Private Group purchase Pharmaceutical Product Development LLC from The Carlyle Group LP (Corporate Private Equity), Hellman & Friedman LLC

Legal Advisor

Advised onThe Carlyle Group LP (Corporate Private Equity), Hellman & Friedman LLC, Pharmaceutical Product Development, Inc. /Private Group purchase Pharmaceutical Product Development LLC

Attorney

Advised onThe Carlyle Group LP (Corporate Private Equity), Hellman & Friedman LLC, Pharmaceutical Product Development, Inc. /Private Group purchase Pharmaceutical Product Development LLC

Legal Advisor

Advised onThe Carlyle Group LP (Corporate Private Equity), Hellman & Friedman LLC, Pharmaceutical Product Development, Inc. /Private Group purchase Pharmaceutical Product Development LLC

Advisors & Consultants
Legal Advisor

Co-Chair, Private Equity Practice Group at Latham & Watkins LLP

Real Estate Agent

Executive Managing Director, Brokerage at Newmark Knight Frank

Advisor

Managing Director at Fennebresque & Co. LLC

Clients

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Almirall SA engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The company operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research and Development Activity, Therapeutic Area of Dermatology in the United States, and Corporate Management and Results not assigned to Other Segments. Its products include treatments for respiratory, autoimmune, dermatological and gastrointestinal diseases. The company was founded in 1943 and is headquartered in Barcelona, Spain.

Inventiva SA engages in the discovery and development of therapies in the area of oncology, fibrosis, and rare diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.

Political Donations
Investments
Details Hidden

Oncofactor Corp. develops antibody drugs against new biologic targets in cancer. Its cancer therapeutics that disrupt signaling pathways between tumors and the immune system. The company was founded by Sarah Ellen Warren in 2011 and is headquartered in Seattle, WA.

Details Hidden

Acylin Therapeutics, Inc. develops drugs for cancer. The company was founded by Philip A. Cole, Peter S. DiStefano, Ronen Marmorstein, Suresh K. Jain and Roydon Price in 2009 and is headquartered in Seattle, WA.

Details Hidden

Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded in 2004 and is headquartered in Durham, NC.

Investors
Details Hidden

ADIA is responsible for investing in private equity globally through externally managed funds and through investments in private companies, typically alongside their external partners. The firm's primary fund investment activities are broadly organized geographically across North America, Europe and emerging markets with strategies such as venture capital, private credit and distressed credit invest with a global mandate.ADIA's secondary and principal investing activities operates worldwide on a global platform with portfolios that is diversified by geography, industry, stage, size and timeframe.

Details Hidden

GIC Pte Ltd. operates as non-commodity-based sovereign wealth fund. It invests in the unlisted public and private equity with a focus on health care, financial and business services. The company was founded by Goh Keng Swee in 1981 and is headquartered in Singapore.

Details Hidden

The Carlyle Group LP (Corporate Private Equity) focuses either on a particular geography (Asia, Europe, Japan, Middle East and North Africa (MENA), South America, Sub-Saharan Africa or the United States) or a particular industry, such as financial services. The firm invests in aerospace, defense & government services, consumer & retail, energy, financial services, healthcare, industrial, real estate, technology & business services, telecommunications & media, and transportation. They provide capital for buyouts and growth capital requirements.

Suppliers
Firstsource Solutions Ltd. Other Business & Consulting Services | Mumbai, MA

Firstsource Solutions Ltd. engages in the provision of customized business process management services. It offers contact center, transaction processing, customer management, healthcare claims administration, underwriting, consulting and debt collection services including revenue cycle management in the healthcare industry. The company was founded on December 6, 2001 and is headquartered in Mumbai, India.

Gramercy Property Trust Trusts & Funds | New York, NY

Gramercy Property Trust operates as an investor and asset manager of commercial real estate, which engages in acquiring and managing single and multi-tenant office properties and a portfolio of specialty retail assets which include retail bank branches, fitness centers and rental car facilities through a net leasing system. The company was founded in April 2004 and is headquartered in New York, NY.

REIT 1 Ltd. Real Estate Investment Trusts | Tel Aviv, TA

REIT 1 Ltd. operates as a real estate investment trust. Its property portfolio includes office buildings, commercial spaces, and industrial properties. REIT 1 operates through Yielding real estate segment. Within this segment it designs, constructs, acquires, leases and maintains assets intended for rent for various uses. The company was founded on April 11, 2006 and is headquartered in Tel Aviv, Israel.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Pharmaceutical Product Development LLC. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Pharmaceutical Product Development LLC's profile does not indicate a business or promotional relationship of any kind between RelSci and Pharmaceutical Product Development LLC.